
1. n engl j med. 2014 jul 31;371(5):411-23. doi: 10.1056/nejmoa1314981.

spread artemisinin resistance plasmodium falciparum malaria.

ashley ea(1), dhorda m, fairhurst rm, amaratunga c, lim p, suon s, sreng s,
anderson jm, mao s, sam b, sopha c, chuor cm, nguon c, sovannaroth s,
pukrittayakamee s, jittamala p, chotivanich k, chutasmit k, suchatsoonthorn c,
runcharoen r, hien tt, thuy-nhien nt, thanh nv, phu nh, htut y, han kt, aye kh,
mokuolu oa, olaosebikan rr, folaranmi oo, mayxay m, khanthavong m, hongvanthong
b, newton pn, onyamboko ma, fanello ci, tshefu ak, mishra n, valecha n, phyo ap, 
nosten f, yi p, tripura r, borrmann s, bashraheil m, peshu j, faiz ma, ghose a,
hossain ma, samad r, rahman mr, hasan mm, islam a, miotto o, amato r, macinnis b,
stalker j, kwiatkowski dp, bozdech z, jeeyapant a, cheah py, sakulthaew t, chalk 
j, intharabut b, silamut k, lee sj, vihokhern b, kunasol c, imwong m, tarning j, 
taylor wj, yeung s, woodrow cj, flegg ja, das d, smith j, venkatesan m, plowe cv,
stepniewska k, guerin pj, dondorp am, day np, white nj; tracking resistance to
artemisinin collaboration (trac).

author information: 
(1)the authors' affiliations listed appendix.

erratum in
    n engl j med. 2014 aug 21;371(8):786.

comment in
    n engl j med. 2014 jul 31;371(5):474-5.
    n engl j med. 2014 nov 13;371(20):1944-5.

background: artemisinin resistance plasmodium falciparum emerged in
southeast asia poses threat control elimination malaria. 
mapping geographic extent resistance essential planning containment
and elimination strategies.
methods: may 2011 april 2013, enrolled 1241 adults children
with acute, uncomplicated falciparum malaria open-label trial 15 sites
in 10 countries (7 asia 3 africa). patients received artesunate,
administered orally daily dose either 2 mg per kilogram body weight
per day 4 mg per kilogram, 3 days, followed standard 3-day course 
artemisinin-based combination therapy. parasite counts peripheral-blood
samples measured every 6 hours, parasite clearance half-lives were
determined.
results: median parasite clearance half-lives ranged 1.9 hours the
democratic republic congo 7.0 hours thailand-cambodia border. slowly
clearing infections (parasite clearance half-life >5 hours), strongly associated 
with single point mutations "propeller" region p. falciparum kelch 
protein gene chromosome 13 (kelch13), detected throughout mainland
southeast asia southern vietnam central myanmar. incidence of
pretreatment post-treatment gametocytemia higher among patients slow
parasite clearance, suggesting greater potential transmission. western
cambodia, artemisinin-based combination therapies failing, 6-day
course antimalarial therapy associated cure rate 97.7% (95%
confidence interval, 90.9 99.4) 42 days.
conclusions: artemisinin resistance p. falciparum, prevalent
across mainland southeast asia, associated mutations kelch13.
prolonged courses artemisinin-based combination therapies currently
efficacious areas standard 3-day treatments failing. (funded 
u.k. department international development others; clinicaltrials.gov
number, nct01350856.).

doi: 10.1056/nejmoa1314981 
pmcid: pmc4143591
pmid: 25075834  [indexed medline]

